Literature DB >> 15892636

Non-steroidal steroid receptor modulators.

Rogier C Buijsman1, Pedro H H Hermkens, Rachel D van Rijn, H Thijs Stock, N Miranda Teerhuis.   

Abstract

The last ten years much attention has been focused on the finding of non-steroidal ligands for steroidal nuclear receptors for reasons such as diminishing cross-reactivity to eliminate side effect profiles, changing physicochemical properties which might cause different tissue distribution profiles and altering binding modes which influence the binding of cofactors. Compounds with a selective functionality profile are referred to as selective nuclear receptor modulators (e.g., SARMs or SPRMs). In the following paragraphs non-steroidal ligands which have full or partial agonistic activity will be described for the following receptors: PR, GR, AR, LXR and FXR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892636     DOI: 10.2174/0929867053764671

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  10 in total

Review 1.  Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5alpha-reductase?

Authors:  Wenqing Gao; James T Dalton
Journal:  Mol Interv       Date:  2007-02

2.  Analysis of selective androgen receptor modulators by gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry.

Authors:  Laura Luosujärvi; Markus Haapala; Mario Thevis; Ville Saarela; Sami Franssila; Raimo A Ketola; Risto Kostiainen; Tapio Kotiaho
Journal:  J Am Soc Mass Spectrom       Date:  2009-11-06       Impact factor: 3.109

3.  Interaction of diuron and related substituted phenylureas with the Ah receptor pathway.

Authors:  Bin Zhao; David S Baston; Bruce Hammock; Michael S Denison
Journal:  J Biochem Mol Toxicol       Date:  2006       Impact factor: 3.642

4.  Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor.

Authors:  Sara H Windahl; René Galien; Riccardo Chiusaroli; Philippe Clément-Lacroix; Frederic Morvan; Liên Lepescheux; François Nique; William C Horne; Michèle Resche-Rigon; Roland Baron
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

Review 5.  Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs).

Authors:  Wenqing Gao; James T Dalton
Journal:  Drug Discov Today       Date:  2007-02-07       Impact factor: 7.851

Review 6.  Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.

Authors:  Wenqing Gao; Juhyun Kim; James T Dalton
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

7.  Tethered indoles as functionalizable ligands for the estrogen receptor.

Authors:  Bridget G Trogden; Sung Hoon Kim; Shuyi Lee; John A Katzenellenbogen
Journal:  Bioorg Med Chem Lett       Date:  2008-11-18       Impact factor: 2.823

Review 8.  Potential future options in the pharmacotherapy of female sexual dysfunction.

Authors:  Stefan Uckert; Margit E Mayer; Udo Jonas; Christian G Stief
Journal:  World J Urol       Date:  2006-12       Impact factor: 3.661

9.  Detection of designer steroids.

Authors:  Xiaohui Yuan; Barry Marc Forman
Journal:  Nucl Recept Signal       Date:  2005-10-21

Review 10.  Selective androgen receptor modulators in preclinical and clinical development.

Authors:  Ramesh Narayanan; Michael L Mohler; Casey E Bohl; Duane D Miller; James T Dalton
Journal:  Nucl Recept Signal       Date:  2008-11-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.